PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 21, 2022Haematologica20 citationsOpen Access

A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials

MYMin YangWZWenhao ZhangKYKang Yu

Key Points

Key points are not available for this paper at this time.

Abstract

Not available.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Yang et al. (2022) studied this question.

synapsesocial.com/papers/6a0ceaf6d09dbb66ef026465https://doi.org/10.3324/haematol.2022.280629
Ask AI
Helpful
Bookmark
Share
View Full Paper